Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

Table 6

Multivariate Cox proportional hazards regression models for overall survival.

Variable	Multivariate analysis
	HR	95% CI	value
Child-Pugh class
B vs. A	0.746	0.185-3.014	0.681
CNLC stage
IIIb vs. IIb and IIIa	2.910	0.599-14.129	0.185
AFP
≥400 vs. <400 ng/ml	1.708	0.602-4.847	0.314
PVTT
Yes vs. none	8.220	1.027-65.788	0.047
SII
≥970 vs. <970	5.564	1.781-17.381	0.003